Research output per year
Research output per year
Search results
-
2020
Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply
Jones, R. H., Casbard, A., Carucci, M., Foxley, A. & Howell, S. J., May 2020, In: The Lancet. Oncology. 21, 5, p. e234 1 p.Research output: Contribution to journal › Letter
-
RE: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer
Howell, S. J., Keevil, B., Higham, C., Owen, L. J. & Monaghan, P. J., 1 Sept 2020, In: European Journal of Cancer. 136, p. 204-205 2 p.Research output: Contribution to journal › Letter › peer-review
-
2019
Association between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene MSH6
Evans, D. G., Howell, S. J. & Peltonen, J., 10 Jan 2019, In: JAMA oncology. 5, 1, p. 119-120 2 p.Research output: Contribution to journal › Letter › peer-review
-
2010
Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen
Ferraldeschi, R., Howell, S. J., Thompson, A. M. & Newman, W. G., 10 Oct 2010, In: Journal of Clinical Oncology. 28, 29, p. e584-e585Research output: Contribution to journal › Letter › peer-review
-
2009
Re: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Howell, S., Wardley, A. M. & Armstrong, A. C., 16 Dec 2009, In: Journal of the National Cancer Institute. 101, 24, p. 1730 1 p.Research output: Contribution to journal › Letter › peer-review